Abstract
This article reviews the theoretical, conceptual and empirical background for the current and growing research on early identification and early intervention to obtain improved outcomes in psychotic disorders. The goal is to prevent episodes of psychosis and the functional disability that accompanies them. Described are the studies linking duration of untreated psychosis and later outcomes, the precedents for psychosis, current methods for assessing the likelihood of onset, and the treatment trials conducted to date. We conclude that the evidence is increasing that justifies early identification and prevention being routine clinical practice. We also conclude that further research needs to refine assessment methods to achieve higher predictive power and that treatments need to be better adapted to the specific conditions usually present during the prodromal period. Finally, larger-scale clinical trials and effectiveness studies need to be carried out to achieve better assessment accuracy and treatment efficacy. Such studies are currently underway in North America and Europe, with results expected in 2012.
Keywords: Clinical high-risk, duration of untreated psychosis, early identification, early intervention, neurocognition, prevention, prodromal psychosis, psychosis, schizophrenia
Adolescent Psychiatry
Title:Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk
Volume: 2 Issue: 2
Author(s): William R. McFarlane, Barbara Cornblatt and Cameron S. Carter
Affiliation:
Keywords: Clinical high-risk, duration of untreated psychosis, early identification, early intervention, neurocognition, prevention, prodromal psychosis, psychosis, schizophrenia
Abstract: This article reviews the theoretical, conceptual and empirical background for the current and growing research on early identification and early intervention to obtain improved outcomes in psychotic disorders. The goal is to prevent episodes of psychosis and the functional disability that accompanies them. Described are the studies linking duration of untreated psychosis and later outcomes, the precedents for psychosis, current methods for assessing the likelihood of onset, and the treatment trials conducted to date. We conclude that the evidence is increasing that justifies early identification and prevention being routine clinical practice. We also conclude that further research needs to refine assessment methods to achieve higher predictive power and that treatments need to be better adapted to the specific conditions usually present during the prodromal period. Finally, larger-scale clinical trials and effectiveness studies need to be carried out to achieve better assessment accuracy and treatment efficacy. Such studies are currently underway in North America and Europe, with results expected in 2012.
Export Options
About this article
Cite this article as:
McFarlane William R., Cornblatt Barbara and Carter Cameron S., Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk , Adolescent Psychiatry 2012; 2 (2) . https://dx.doi.org/10.2174/2210676611202020125
DOI https://dx.doi.org/10.2174/2210676611202020125 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides
Current Pharmaceutical Design Identifying Structural Features Related to the Biological Activity of a Series of AT1 Antagonists from Fragment-based Drug Design
Protein & Peptide Letters A More Radical Solution
Reviews on Recent Clinical Trials Editorial (Thematic Issue: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part I))
Current Molecular Pharmacology Effect of Dietary Supplementation of Black Seed (N. Sativa L.) on Lipid Profile of Patients Suffering from Diabetes
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Advances in Developing K-Ras Plasma Membrane Localization Inhibitors
Current Topics in Medicinal Chemistry Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Relevance of Sphingolipids in the Pleiotropic Protective Effects of High-Density Lipoproteins
Current Pharmaceutical Design Surgical Ventricular Restoration: An Operation to Reverse Remodeling - Clinical Application (Part II) (Supplementry Table)
Current Cardiology Reviews Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Effect of Hyperthermia and Triblock Copolymeric Nanoparticles as Quercetin Carrier on DU145 Prostate Cancer Cells
Current Nanoscience Fermentation of Beet Juice Using Lactic Acid Bacteria and its Cytotoxic Activity Against Human Liver Cancer Cell Lines HepG2
Current Bioactive Compounds Analysis of Current Antifungal Agents and Their Targets within the Pneumocystis carinii Genome
Current Drug Targets The Efficacy of Stepped Care Models Involving Psychosocial Treatment of Alcohol Use Disorders and Nicotine Dependence: A Systematic Review of the Literature
Current Drug Abuse Reviews Cardiac Protection via Metabolic Modulation: An Emerging Role for Incretin-Based Therapies?
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Statins in Preventing the Progression of Congestive Heart Failure in Patients with Metabolic Syndrome
Current Pharmaceutical Design Direct Somatic Cell Reprogramming: Treatment of Cardiac Diseases
Current Gene Therapy A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Current Topics in Medicinal Chemistry The Etiology of Hypertension in the Metabolic Syndrome Part Two: The Gene-Environment Interaction
Current Vascular Pharmacology Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design